Analgesic, Respiratory and Heart Rate Effects of Cannabinoid and Opioid Agonists in Rhesus Monkeys: Antagonist Effects of SR 141716A

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,751 · see citing works

Cardiovascular effects of anemia

Varat, M. A., Adolph, R. J., & Fowler, N. O. (1972) · American Heart Journal · doi:10.1016/0002-8703(72)90445-0 · Cited by 431 · see citing works

The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

Smith, P. B., Compton, D. M., Welch, S. P., Razdan, R. K., Mechoulam, R., & Martin, B. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22356-4 · Cited by 394 · see citing works

In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

Compton, D. M., Aceto, M. D. G., Lowe, J. A., III, & Martin, B. R. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12911-x · Cited by 357 · see citing works

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

Herzberg, U., Eliav, E., Bennett, G. J., & Kopin, I. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13308-5 · Cited by 307 · see citing works

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Rinaldi, M. L., Barth, F., Héaulme, M., Alonso, R., Shire, D. J., Congy, C., Soubrié, P., Brelière, J.-C., & Fur, G. L. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00174-5 · Cited by 303 · see citing works

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

Terranova, J.-P., Storme, J.-J., Lafon, N., Perio, A., Rinaldi, M. L., Fur, G. L., & Soubrié, P. (1996) · Psychopharmacology · doi:10.1007/bf02246352 · Cited by 283 · see citing works

Δ9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism

Lichtman, A. H., & Martin, B. R. (1996) · Psychopharmacology · doi:10.1007/bf02246347 · Cited by 213 · see citing works

Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.

Welch, S. P., & Stevens, D. L. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10720-9 · Cited by 208 · see citing works

Physical withdrawal in rats tolerant to Δ9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

Tsou, K., Patrick, S. L., & Walker, J. M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00360-w · Cited by 173 · see citing works

Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.

Aceto, M. D. G., Scates, S. M., Lowe, J. A., III, & Martin, B. R. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20781-9 · Cited by 168 · see citing works

Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain

Rinaldi, M. L., Pialot, F., Congy, C., Redon, E., Barth, F., Bachy, A., Brelière, J.-C., Soubrié, P., & Fur, G. L. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00085-9 · Cited by 132 · see citing works

Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.

Fan, F., Compton, D. M., Ward, S. J., Melvin, L. S., & Martin, B. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24023-x · Cited by 126 · see citing works

Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.

Wiley, J. L., Lowe, J. A., III, Balster, R. L., & Martin, B. R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12022-3 · Cited by 126 · see citing works

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

Wiley, J. L., Barrett, R. L., Lowe, J. A., III, Balster, R. L., & Martin, B. R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00027-4 · Cited by 122 · see citing works

Regional Cerebral Blood Flow after Marijuana Smoking

Mathew, R. J., Wilson, W. H., Humphreys, D. F., Lowe, J. V., & Wiethe, K. E. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.106 · Cited by 112 · see citing works

Cannabinoid receptor stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding in rat brain membranes

Selley, D. E., Stark, S., Sim, L. J., & Childers, S. R. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00347-5 · Cited by 111 · see citing works

Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptors

Reche, I., Fuentes, J. A., & Ruiz-Gayo, M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00752-2 · Cited by 87 · see citing works

A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys

Dykstra, L., & Woods, J. H. (1986) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(86)90056-2 · Cited by 84 · see citing works

Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord

Pugh, G., Mason, D. J., Combs, V., & Welch, S. P. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36640-6 · Cited by 81 · see citing works

Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.

Welch, S. P., Dunlow, L. D., Patrick, G., & Razdan, R. K. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09617-x · Cited by 79 · see citing works

Discriminative stimulus effects of anandamide in rats

Wiley, J. L., Balster, R. L., & Martin, B. R. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00010-i · Cited by 74 · see citing works

Pharmacological specificity of the discriminative stimulus effects of Δ9-tetrahydrocannabinol in rhesus monkeys

Wiley, J. L., Huffman, J. W., Balster, R. L., & Martin, B. R. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01193-5 · Cited by 70 · see citing works

A role for central cannabinoid and opioid systems in peripheral Δ9-tetrahydrocannabinol-induced analgesia in mice

Reche, I., Fuentes, J. A., & Ruiz‐Gayo, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00045-3 · Cited by 64 · see citing works

Intravenous Δ9-Tetrahydrocannabinol

Malit, L. A., Johnstone, R. E., Bourke, D. L., Kulp, R. A., Klein, V., & Smith, T. C. (1975) · Anesthesiology · doi:10.1097/00000542-197506000-00008 · Cited by 58 · see citing works

Cardiovascular Effects of (-)-11-OH-Δ8-Tetrahydrocannabinol-Dimethylheptyl in Rats

Vidrio, H., Sánchez‐Salvatori, M. A., & Medina, M. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199608000-00022 · Cited by 56 · see citing works

Preference for high- versus low-potency marijuana

Chait, L. D., & Burke, K. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90082-5 · Cited by 52 · see citing works

Cannabinoids. I. Behavioral effects.

Stark, P., & DEWS, P. B. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32141-5 · Cited by 51 · see citing works

Combination of Δ9-Tetrahydrocannabinol with Oxymorphone or Pentobarbital

Johnstone, R. E., Lief, P. L., Kulp, R. A., & Smith, T. C. (1975) · Anesthesiology · doi:10.1097/00000542-197506000-00009 · Cited by 45 · see citing works

Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys.

Howell, L. L., Bergman, J., & Morse, W. H. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22291-1 · Cited by 45 · see citing works

Antisense oligodeoxynucleotides to the κ-1 receptor block the antinociceptive effects of Δ9-THC in the spinal cord

Pugh, G., Abood, M. E., & Welch, S. P. (1995) · Brain Research · doi:10.1016/0006-8993(95)00560-d · Cited by 33 · see citing works

Morphine and ?9-tetrahydrocannabinol: Two-way cross tolerance for antinociceptive and heart-rate responses in the rat

Hine, B. (1985) · Psychopharmacology · doi:10.1007/bf00431774 · Cited by 31 · see citing works

Cardiovascular effects of Δ9- andΔ9(11)-tetrahydrocannabinol and their interaction with epinephrine

Estrada-Robles, U., Brase, D. A., Martin, B. R., & Dewey, W. L. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90559-5 · Cited by 27 · see citing works

The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys.

Fredericks, A., Benowitz, N. L., & Savanapridi, C. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32409-2 · Cited by 25 · see citing works

Response to marijuana as a function of potency and breathhold duration

Zacny, J. P., & Chait, L. D. (1991) · Psychopharmacology · doi:10.1007/bf02244207 · Cited by 24 · see citing works

Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrazone (NalBZH)

Welch, S. P. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90245-3 · Cited by 21 · see citing works

Δ9-Tetrahydrocannabinol: EEG changes, bradycardia and hypothermia in the rhesus monkey

Matsuzaki, M., Casella, G. A., & Ratner, M. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90087-6 · Cited by 18 · see citing works

Analgesic, Heart Rate, and Temperature Effects of Δ 8 -THC during Acute and Chronic Administration to Conscious Rats

Hine, B., Torrelio, M., & Gershon, S. (2008) · Pharmacology · doi:10.1159/000136664 · Cited by 18 · see citing works

The effects of cannabinoids on the brain

Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 805 · see citing works

Cannabinoid receptors and pain

Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741 · see citing works

Pharmacological and biochemical interactions between opioids and cannabinoids

Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 391 · see citing works

The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications

Lambert, D. M., & Fowler, C. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058183t · Cited by 350 · see citing works

Direct inhibition of T‐type calcium channels by the endogenous cannabinoid anandamide

Chemin, J., Monteil, A., Perez‐Reyes, E., Nargeot, J., & Lory, P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7033 · Cited by 299 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors

Ghozland, S. G., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263 · see citing works

The Endomorphin System and Its Evolving Neurophysiological Role

Fichna, J., Janecka, A. E., Costentin, J., & do-Rego, J.-C. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.1.3 · Cited by 249 · see citing works

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol

Boggs, D. L., Nguyen, J. D., Morgenson, D., Taffe, M. A., & Ranganathan, M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.209 · Cited by 236 · see citing works

The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions

Naef, M., Curatolo, M., Petersen-Felix, S., Arendt-Nielsen, L., Zbinden, A., & Brenneisen, R. (2003) · Pain · doi:10.1016/s0304-3959(03)00163-5 · Cited by 209 · see citing works

Cannabinoid Mechanisms of Pain Suppression

Walker, J. M., & Hohmann, A. G. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 177 · see citing works

Sex differences in antinociceptive and motoric effects of cannabinoids.

Tseng, A. H., & Craft, R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01267-5 · Cited by 156 · see citing works

Cannabinoid-Induced Presynaptic Inhibition of Glutamatergic EPSCs in Substantia Gelatinosa Neurons of the Rat Spinal Cord

Morisset, V., & Urbán, L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.1.40 · Cited by 152 · see citing works

Self-administration of cannabinoids by experimental animals and human marijuana smokers

Justinová, Z., Goldberg, S. R., Heishman, S. J., & Tanda, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.026 · Cited by 137 · see citing works

Molecular biology of cannabinoid receptors

Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 135 · see citing works

Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists

Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 134 · see citing works

Antinociceptive, subjective and behavioral effects of smoked marijuana in humans

Greenwald, M. K., & Stitzer, M. L. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00128-3 · Cited by 119 · see citing works

The opioid antagonist naltrexone reduces the reinforcing effects of ? 9 -tetrahydrocannabinol (THC) in squirrel monkeys

Tanda, G., Munzar, P., Goldberg, S. R., & Justinova, Z. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1693-6 · Cited by 111 · see citing works

Cannabinoids modulate pain by multiple mechanisms of action

Richardson, J. D. (2000) · The Journal of Pain · doi:10.1016/s1526-5900(00)90082-8 · Cited by 109 · see citing works

The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice

Shafaroodi, H., Samini, M., Moezi, L., Homayoun, H., Sadeghipour, H., Tavakoli, S., Hajrasouliha, A. R., & Dehpour, A. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.04.011 · Cited by 105 · see citing works

The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression

Niederhoffer, N., Schmid, K., & Szabó, B. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0755-y · Cited by 100 · see citing works

Δ9-Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors

Krowicki, Z. K., Moerschbaecher, J. M., Winsauer, P. J., Sivarao, D. V., & Hornby, P. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00165-x · Cited by 94 · see citing works

Endogenous opiates: 1998☆

Vaccarino, A. L., Olson, G. A., Olson, R. D., & Kastin, A. J. (1999) · Peptides · doi:10.1016/s0196-9781(99)00166-7 · Cited by 89 · see citing works

Reduction in Opioid- and Cannabinoid-Induced Antinociception in Rhesus Monkeys after Bilateral Lesions of the Amygdaloid Complex

Manning, B. H., Merin, N. M., Meng, I. D., & Amaral, D. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08238.2001 · Cited by 88 · see citing works

Endocannabinoids in cerebrovascular regulation

Benyó, Z., Ruisanchez, É., Leszl-Ishiguro, M., Sándor, P., & Pacher, P. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00571.2015 · Cited by 87 · see citing works

Possible mechanisms of cannabinoid-induced antinociception in the spinal cord

Morisset, V., Ahluwalia, J. P., Nagy, I., & Urbán, L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01309-7 · Cited by 86 · see citing works

Interaction between naltrexone and oral THC in heavy marijuana smokers

Haney, M., Bisaga, A. M., & Foltin, R. W. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1279-8 · Cited by 83 · see citing works

Marijuana Withdrawal Syndrome in the Animal Model

Lichtman, A. H., & Martin, B. R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05999.x · Cited by 78 · see citing works

Cannabinoids as potential new analgesics

Fuentes, J., Ruiz‐Gayo, M., Manzanares, J., Vela, G., Reche, I., & Corchero, J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00290-8 · Cited by 72 · see citing works

Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration

Maguire, D. R., Yang, W., & France, C. P. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204099 · Cited by 71 · see citing works

Central effects of the cannabinoid receptor agonist WIN55212‐2 on respiratory and cardiovascular regulation in anaesthetised rats

Pfitzer, T., Niederhoffer, N., & Szabó, B. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705874 · Cited by 68 · see citing works

Unconditioned Behavioral Effects of the Powerful κ-Opioid Hallucinogen Salvinorin A in Nonhuman Primates: Fast Onset and Entry into Cerebrospinal Fluid

Butelman, E. R., Prisinzano, T. E., Deng, H., Rus, S., & Kreek, M. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145342 · Cited by 66 · see citing works

A Common Molecular Basis for Exogenous and Endogenous Cannabinoid Potentiation of Glycine Receptors

Xiong, W., Wu, X., Lovinger, D. M., & Li, Z. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6347-11.2012 · Cited by 62 · see citing works

Impact of Efficacy at the μ-Opioid Receptor on Antinociceptive Effects of Combinations of μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists

Maguire, D. R., & France, C. P. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216648 · Cited by 59 · see citing works

Local administration of Δ 9 -tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action

Ko, M., & Woods, J. H. (1999) · Psychopharmacology · doi:10.1007/s002130050955 · Cited by 58 · see citing works

Analysis of the respiratory effects of cannabinoids in rats

Schmid, K., Niederhoffer, N., & Szabó, B. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0787-3 · Cited by 54 · see citing works

Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist

Fosgerau, K., Weber, U. J., Gotfredsen, J. W., Jayatissa, M. N., Buus, C., Kristensen, N. B., Vestergaard, M., Teschendorf, P., Schneider, A., Hansen, P., et al. (2010) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-10-51 · Cited by 47 · see citing works

Cannabinoids, endogenous ligands and synthetic analogs

Pop, E. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80062-3 · Cited by 45 · see citing works

Rimonabant-Induced Δ9-Tetrahydrocannabinol Withdrawal in Rhesus Monkeys: Discriminative Stimulus Effects and Other Withdrawal Signs

Stewart, J. L., & McMahon, L. R. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168435 · Cited by 43 · see citing works

Role of Cannabinoid Receptor in the Brain as It Relates to Drug Reward

Yamamoto, T., & Takada, K. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.84.229 · Cited by 41 · see citing works

Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner

Amorós, I., Barana, A., Caballero, R., Gómez, R. J., Osuna, L., Lillo, M. P., Tamargo, J. L., & Delpón, E. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.011 · Cited by 40 · see citing works

Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

Weresa, J., Pędzińska‐Betiuk, A., Mińczuk, K., Malinowska, B., & Schlicker, E. (2022) · Cells · doi:10.3390/cells11071142 · Cited by 36 · see citing works

Synthesis and CB1 cannabinoid receptor affinity of 4-alkoxycarbonyl-1,5-diaryl-1,2,3-triazoles

Shu, H., Izenwasser, S., Wade, D., Stevens, E. D., & Trudell, M. L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.110 · Cited by 36 · see citing works

Interactions between Δ9-tetrahydrocannabinol and heroin

Li, J., Koek, W., & France, C. P. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32835a3907 · Cited by 36 · see citing works

Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects

Sadhasivam, S., Zhang, X., Chidambaran, V., Mavi, J., Pilipenko, V. V., Baye, T. M., Meller, J., Kaufman, K. M., Martin, L. J., & McAuliffe, J. J. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.79 · Cited by 36 · see citing works

Modulation of T-type calcium channels by bioactive lipids

Chemin, J., Cazade, M., & Lory, P. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1467-5 · Cited by 35 · see citing works

Cannabinoids Facilitate the Swallowing Reflex Elicited by the Superior Laryngeal Nerve Stimulation in Rats

Mostafeezur, R. M., Zakir, H. M., Takatsuji, H., Yamada, Y., Yamamura, K., & Kitagawa, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050703 · Cited by 31 · see citing works

SR 141716A differentially attenuates the behavioral effects of ??9-THC in rhesus monkeys

McMahon, L. R., Amin, M. R., & France, C. P. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00008 · Cited by 30 · see citing works

Focus on the Three Key Enzymes Hydrolysing Endocannabinoids as New Drug Targets

Vandevoorde, S., & Lambert, D. M. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054546914 · Cited by 26 · see citing works

Ultra-low dose naltrexone enhances cannabinoid-induced antinociception

Paquette, J. J., & Olmstead, M. C. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200512000-00001 · Cited by 26 · see citing works

Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys

Gerak, L. R., Maguire, D. R., Woods, J. H., Husbands, S. M., Disney, A., & France, C. P. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.253286 · Cited by 26 · see citing works

Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys

Gerak, L. R., Zanettini, C., Koek, W., & France, C. P. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4023-x · Cited by 25 · see citing works

Operant nociception in nonhuman primates

Kangas, B. D., & Bergman, J. (2014) · Pain · doi:10.1016/j.pain.2014.06.010 · Cited by 22 · see citing works

Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys

Weed, P. F., Gerak, L. R., & France, C. P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.041 · Cited by 21 · see citing works

Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Δ9-tetrahydrocannabinol

McMahon, L. R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1230-8 · Cited by 21 · see citing works

Cannabinoid receptor expression in peripheral arterial chemoreceptors during postnatal development

McLemore, G. L., Cooper, R., Richardson, K. A., Mason, A. V., Marshall, C., Northington, F. J., & Gauda, E. B. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00378.2004 · Cited by 20 · see citing works

Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study

Freedland, C. S., Whitlow, C. T., Smith, H. R., & Porrino, L. J. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03999-9 · Cited by 18 · see citing works

Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and ß-funaltrexamine

Negus, S. S., Brandt, M. R., Gatch, M. B., & Mello, N. K. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00331-9 · Cited by 17 · see citing works

Efficacy of cannabinoids in fibromyalgia: a literature review

Anaya, H. J. M., Ortiz, M. P. T., Valencia, D. H. F., & Ribero, O. F. G. (2021) · Colombian Journal of Anesthesiology · doi:10.5554/22562087.e980 · Cited by 13 · see citing works

The Contribution of cocoa additive to cigarette smoking addiction

Rambali, B., van, A. I., Schenk, E., Wolterink, G., van de, W. G., Stevenson, H. A., & Vleeming, W. (2003) · Rivm Repository (Netherlands National Institute for Public Health and the Environment) · Cited by 13 · see citing works

Gene Therapy for the Management of Pain

Wu, C. L., Garry, M. G., Zollo, R. A., & Yang, J. (2001) · Anesthesiology · doi:10.1097/00000542-200107000-00033 · Cited by 13 · see citing works

Endocrine and other responses to acute administration of cannabinoid compounds to non-stressed male calves

Zenor, B. N., Weesner, G. D., & Malven, P. V. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00229-5 · Cited by 12 · see citing works

Identification of the role of endogenous cannabinoids in pain modulation: strategies and pitfalls

Walker, J. M., Huang, S. M., Strangman, N. M., & Sañudo-Peña, M. C. (2000) · Journal of Pain · doi:10.1016/s1526-5900(00)90085-3 · Cited by 12 · see citing works

CB1 receptor-mediated respiratory depression by endocannabinoids

Iring, A., Hricisák, L., & Benyó, Z. (2017) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2017.02.011 · Cited by 12 · see citing works

CB1 cannabinoid receptor agonists induce acute respiratory depression in awake mice

Watkins, J. M., Aradi, P., Hahn, R., Makriyannis, A., Mackie, K., Katona, I., & Hohmann, A. G. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107682 · Cited by 9 · see citing works

The Development of Cannabinoids as Therapeutic Agents in the United States

Murray, C. H., Gannon, B. M., Winsauer, P. J., Cooper, Z. D., & Delatte, M. S. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001121 · Cited by 9 · see citing works

A method for conducting functional MRI studies in alert nonhuman primates: Initial results with opioid agonists in male cynomolgus monkeys.

Kaufman, M. J., Janes, A. C., Frederick, B. B., Brimson-Théberge, M., Tong, Y., McWilliams, S. B., Bear, A., Gillis, T. E., Schrode, K. M., Renshaw, P. F., et al. (2013) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0033062 · Cited by 8 · see citing works

Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors

Gerak, L. R., Maguire, D. R., & France, C. P. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_265 · Cited by 8 · see citing works

Cannabinoid CB 2 Receptor Activation Attenuates Fentanyl-Induced Respiratory Depression

Zavala, C. A., Thomaz, A. C., Iyer, V., Mackie, K., & Hohmann, A. G. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0059 · Cited by 7 · see citing works

Endomorphin peptides: pharmacological and functional implications of these opioid peptides in the brain of mammals. Part one

Leff, P., Herrera, N., Matus-Ortega, M., Romero, L. P., Santillán, C. T., Juárez, A., & Palma, B. A. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 7 · see citing works

Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice

James, J. C., Thrush, J. R., Yusufali, T. M., Shaw, H. E., Avram, M., Moran, J. H., & Fantegrossi, W. E. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112672 · Cited by 6 · see citing works

β-caryophyllene inhibits heroin self-administration, but does not alter opioid-induced antinociception in rodents

Galaj, E., Bi, G., & Xi, Z. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109947 · Cited by 6 · see citing works

Cannabinoidergic Regulation of the Functional State of the Heart. The Role of the Autonomic Nervous System

Krylatov, A. V., Маслов, Л. Н., Nam, I., & Bushov, Y. V. (2019) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-019-00736-w · Cited by 6 · see citing works

Functional role for preoptic CB1 receptors in breathing and thermal control

Ripamonte, G. C., Bernardes-Ribeiro, M., Patrone, L. G. A., Vicente, M. C., Bícego, K. C., & Gargaglioni, L. H. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135021 · Cited by 6 · see citing works

Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit

Clarke, R. W., Harris, J. E., Jenkins, S., & Witton, S. K. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00179-9 · Cited by 6 · see citing works

Δ9-Tetrahydrocannabinol Effects on Respiration and Heart Rate Across Route of Administration in Female and Male Mice

Laudermilk, L. T., Marusich, J. A., & Wiley, J. L. (2023) · Cardiovascular Toxicology · doi:10.1007/s12012-023-09810-9 · Cited by 5 · see citing works

Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture

Morris, T. M., Cucinello‐Ragland, J. A., Marks, T. J., Prevost, K., Glenn, J. F., Davenport, G. J., Edwards, S., & Winsauer, P. J. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173692 · Cited by 5 · see citing works

39th Annual European Brain and Behaviour Society Abstracts

Treves, E. B. A., Battaglini, P. P., Chelazzi, L., Diamond, M. E., & Vallortigara, G. (2007) · Neural Plasticity · doi:10.1155/2007/23250 · Cited by 5 · see citing works

Opioid System Involvement in Cannabinoid Tolerance and Dependence

Maldonado, R. J. (1882) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_12 · Cited by 5 · see citing works

Effects of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC:CBD mixtures on behavioral and physiological signs of morphine withdrawal in rhesus monkeys

Carey, L. M., Galbo, L. K., Maguire, D. R., & France, C. P. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103671 · Cited by 4 · see citing works

Supranodose vagotomy eliminates anandamide-evoked cardiorespiratory depression in anaesthetized rats

Kopczyńska, B., & Szereda‐Przestaszewska, M. (2005) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2005.07.007 · Cited by 4 · see citing works

Targeting G protein coupled receptors for alleviating neuropathic pain

Kumari, P., Yadav, A., Patel, M., & Yadav, P. N. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.004 · Cited by 3 · see citing works

Use of cannabis in medicine and pharmacy

Goločorbin-Kon, S., Pavlović, N., Rašković, A., Lalic-Popovic, M. N., Milić, N., Milosevic, N. P., & Mikov, M. (2015) · Medicinski casopis · doi:10.5937/mckg49-9796 · Cited by 3 · see citing works

DOSE-DEPENDENT EFFECTS ON VENTILATION AT REST INDUCED BY HIGH DOSES OF CANNABINOIDS IN RATS

Duarte, T., Houzé, P., Risède, P., Pope, C., Scherrmann, J., & Baud, F. J. (2010) · Acta Clinica Belgica · doi:10.1179/acb.2010.115 · Cited by 1 · see citing works

Opioid Overdose

Jones, J. D., Luba, R. R., Mumtaz, M., & Castillo, F. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.30 · Cited by 1 · see citing works

The Effects of Synthetic Cannabinoids on Alveolar-Arterial Oxygen Gradient

Küçük, E. (2016) · The Annals of Clinical and Analytical Medicine · doi:10.4328/jcam.3153 · Cited by 1 · see citing works

Respiratorische Insuffizienz durch Delta-9-Tetrahydrocannabinol bei tetraplegischem Patienten

Neuburger, M., Schley, M. T., Schmelz, M., Schuepfer, G., & Konrad, C. J. (2006) · Der Schmerz · doi:10.1007/s00482-006-0474-7

Design, Synthesis and Biological Evaluation of novel cannabinoid antagonists

Verma, A. (2012)

Administration of a Cannabinoid Receptor Antagonist Following Chronic ∆ 9 -Tetrahydrocannabinol Induces Physical Withdrawal in the Absence of a Dysphoric State

Ford, B. (2010) · Scholars Commons (Wilfrid Laurier University)

Contribution à l'étude de la morbi-mortalité lors de l'usage de drogues récréatives : GHB-THC, seuls ou associés à l'éthanol

Roussel, O. (2012) · doi:10.70675/19b792cfzac4ez4096z88d6zb406b8e2e98d

Synthesis of Dibenzofurans via a Palladium Catalyzed Oxidative Ring Closure Reaction

Akram, S. (2013) · ScholarWorks @ The University of New Orleans (The University of New Orleans)

Ultra-Low Dose Antagonist Effects on Cannabinoids and Opioids in Models of Pain: Is Less More?

Paquette, J. J. (2007)

Cannabinoid modulation of nociception and nociceptor activity during inflammation.

Potenzieri, C. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)

CANNABINOIDERGIC REGULATION OF FUNCTIONAL STATE OF HEART (PART I)

Krylatov, A. V., Serebrov, V. Y., Ваизова, О. Е., & Dyakova, E. Y. (2017) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2017-32-3-7-13

The Efficacy of Cannabidiol in Mitigating Delta-9-Tetrahydrocannabinol-induced Harms: A Systematic Review

de Freitas, & Alyson, L. (2020)

Effets comportementaux des cannabinoïdes Données animales

Thiébot, M.-H., & Chaperon, F. (2001) · Douleur et Analgésie · doi:10.1007/bf03012691

U 69593

Feller, D. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.62830-2

BindingDB Entry 50027959: Synthesis and CB1 cannabinoid receptor affinity of 4-alkoxycarbonyl-1,5-diaryl-1,2,3-triazoles.

BindingDB (2010) · UC San Diego · doi:10.7270/q2ns0tr7

Untitled work

(2000) · doi:10.1002/1098-2396(20001215)38:4

Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception

Li, J., McMahon, L. R., Gerak, L. R., Becker, G. L., & France, C. P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1157-0 · Cited by 57 · see citing works

Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration

Maguire, D. R., Yang, W., & France, C. P. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204099 · Cited by 71 · see citing works

SR 141716A differentially attenuates the behavioral effects of ??9-THC in rhesus monkeys

McMahon, L. R., Amin, M. R., & France, C. P. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00008 · Cited by 30 · see citing works

Opioid Interactions in Rhesus Monkeys: Effects of δ + μ and δ + κ Agonists on Schedule-Controlled Responding and Thermal Nociception

Stevenson, G. W., Folk, J. E., Linsenmayer, D. C., Rice, K. C., & Negus, S. S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056515 · Cited by 64 · see citing works

JPET #56515 1

Stevenson, G. W., Folk, J. E., Linsenmayer, D. C., Rice, K. C., & Negus, S. S. (2015)